Zentalis Pharmaceuticals, Inc.
$338.94M- Market cap
- $290.27M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 5.03x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · current priceP/S 4.31x
$4.05Latest market snapshot
Implied fair value · at FLO's multiple
$0.2494.1% below market
0.94 ZNTL revenue / share×0.25x FLO P/S=$0.24
Market $4.05Implied $0.24
FLO · current priceP/S 0.25x
$6.28Latest market snapshot
Implied fair value · at ZNTL's multiple
$106.711,599.3% above market
24.79 FLO revenue / share×4.31x ZNTL P/S=$106.71
Market $6.28Implied $106.71